Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pauline Vaflard

3PUBLICATIONS

16CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 28, 2024

Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

A Rault, S Dolbeault, J Terrasson

|Feb 25, 2024

Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.

Alexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré

|Jan 07, 2022

Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.

Sarah Watson, Joanna Cyrta, Marine Lefevre

Pageof 1

Frequent Collaborators

2 joint publications

Paul Cottu

1 joint publications

A Rault

1 joint publications

S Dolbeault

1 joint publications

J Terrasson

1 joint publications

C Bouleuc

1 joint publications

S Piperno-Neumann

1 joint publications

M Rodrigues

1 joint publications

A Brédart

1 joint publications

Sarah Watson

1 joint publications

Julien Masliah Planchon

Frequent Collaborators

2 joint publications

Paul Cottu

1 joint publications

A Rault

1 joint publications

S Dolbeault

1 joint publications

J Terrasson

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Assessing Specificity of Anticancer Drugs <em>In Vitro</em>

Assessing Specificity of Anticancer Drugs <em>In Vitro</em>

Published on : Mar 23, 2016

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on : Feb 16, 2024

See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

Assessing Specificity of Anticancer Drugs <em>In Vitro</em>

Assessing Specificity of Anticancer Drugs <em>In Vitro</em>

Published on : Mar 23, 2016

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on : Feb 16, 2024

See more related videos